Europace

Article	Citations
How can we assess the risk for sudden cardiac death to decide for primary prophylactic implantable cardioverter-defibrillator in patients with heart failure in 2022?	497
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	345
Atrial cardiomyopathy delays the endothelialization process of left atrial appendage occluders	303
Jailed or freed? The lead dilemma in transcatheter tricuspid valve replacement	258
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study	213
Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation	209
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience	167
Transvenous lead extraction: Experience of the Tandem approach	162
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators	158
Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study	144
Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the nat	144
The Wolff–Parkinson–White pattern in neonates: results from a large population-based cohort study	133
Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review	112
Carbon footprint of atrial fibrillation catheter ablation	111
Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained	108
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	104
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	101
Impact of pulsed-field ablation on kidney function	101
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	100
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	95
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	93
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	93
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	84
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	80
Failed shocks in hypertrophic cardiomyopathy patients: prevalence, predictors and outcome	78

Left bundle branch area pacing: predictors of success	77
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	72
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	71
Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	65
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	65
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	64
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	62
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	62
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	62
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	62
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	62
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	61
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	59
Prevalence and clinical impact of major incidental findings detected on routine cardiovascular resonance imaging prior to catheter ablation of atrial fibrillation	58
Computed tomography as a predictive tool for ventricular tachycardia	57
Interpolation of electrophysiology parameters using OpenEP: technology development and clinical application	56
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	56
Atrial endomysial fibrosis is associated with sex, atrial fibrillation, heart failure and age in cardiac surgery patients: results from the Catch-Me consortium	55
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	55
Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	54
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	54
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	52
Pre-diabetes increases the risk of heart failure among patients with nonvalvular atrial fibrillation	51
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	50
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	50
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	50
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	50
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy	49
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	49
Atrioventricular nodal reentrant tachycardia ablation (avnrt), a female disease. insights from the german ablation registry	49
Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	48
Advanced vascular aging in patients with paroxysmal atrial fibrillation - Data from RACE V	48
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	48
High-density sequential mapping of repetitive atrial conduction patterns during atrial fibrillation	48
The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter	47
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	47
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	47
First experience of focal pulsed field ablation for premature ventricular contractions	47
Impaired heart rate variability triangular index predicts stroke and systemic embolism in patients with atrial fibrillation	46
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	46
Discussions on implantable cardioverter defibrillator deactivation in patients receiving radiation therapy	46
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study	45
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation	45
Hemolysis after atrial fibrillation ablation conducted with a new point-by-point pulsed field ablation device	45
MicroPort CRM considerations on Vega pacing lead performance	44
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort	44
Pacemaker dependency after Cox Maze procedure concomitant with cardiac surgery, The road between Scylla and Charybdis	44
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion	44
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings	43
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation	43

LAT velocity vectors: a novel tool for ventricular functional substrate characterization	42
Impact of additional pulsed field ablation in unsuccessful radiofrequency linear lesions -acute and chronic data	41
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction	41
Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank	41
Left atrial epicardial adipose tissue: correlation to left atrial fibrosis and arrhythmia recurrence post atrial fibrillation ablation	41
Does the rhythm have an additional effect - left atrial strain measurement in heart failure patients with HFrEF and in patients with atrial fibrillation and preserved ejection fraction	40
Identification of a real-world clinical model associated with atrial fibrillation in a large french primary care database	40
Ultra-high density mapping and ablation of localized microreentrant tachycardias: insight from the CHARISMA registry	40
A Bayesian meta-analysis on recurrence of atrial arrhythmia between Hybrid AF ablation and endocardial AF ablation	39
The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation	39
Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis	39
Left-sided slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center experience	39
Pulsed field ablation of persistent and long-standing persistent atrial fibrillation: acute safety, efficacy and long-term outcome from a nationwide experience	38
Simplification of resetting response in slow/fast atrioventricular nodal reentrant tachycardia: the 3 catheters approach	38
The predictive ability of the QT response in supine-standing test for drug induced QT prolongation	38
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke	37
Imaging-derived tissue visualization guides catheter ablation of premature ventricular contractions	37
Different predictors of AF recurrence after pulmonary vein isolation with cryoballoon and radiofrequency ablation: insights from clinical and electroanatomical mapping data of the NO-PERSAF study	37
The novel POLARx ablation system improves cryothermal single-shot guided pulmonary vein isolation: impact of individual pulmonary vein anatomy	36
Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with non-ischemic dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden card	36
Utilising the pericardial CO2 insufflation technique to facilitate endo-epicardial AF ablation, achieving linear radiofrequency lesion sets, for persistent atrial fibrillation	36
Device-lead abnormalities and function after transcatheter tricuspid valve replacement	35
Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry	35
Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators	35
Prevalence and characteristics of arrhythmias during the pregnancy	35
Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review	35
Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network	35
Cardioneuroablation for treatment of atrioventricular block: to cure the patient or the electrocardiogram?	34
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study	34
Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapy	33
Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome	33
Novel four-exon deletion in ryanodine receptor gene (RYR2) associated with mixed electric and structural cardiac phenotype	33
State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), an	33
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	33
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?	33
Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients	32
Underlying reasons for sex difference in survival following out-of-hospital cardiac arrest: a mediation analysis	32
Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach	32
Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events	31
Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of ‘ground truth’	31
Permanent epicardial pacing : a first line strategy in children	31
Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study	31
Clinical impact of capsulectomy during cardiac implantable electronic device generator replacement: a prospective randomized trial	31
Promoting differentiation of human-induced pluripotent stem cells into sinoatrial node-like cells through programmed regulation of AMPK signalling pathway	31
Atrial fibrillation and heart failure temporality: does it matter?	30
Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness?	30
Correction to: Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology	30
Evaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall	30
Corrigendum to: Infanticide vs. inherited cardiac arrhythmias	30
Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review	30
Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre	30
Manual compression versus modified figure-of-8 stitch after left atrial ablations: a comparative randomized trial	30
Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry	30
Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy	30
Zero- and minimal fluoroscopic approaches during ablation of supraventricular tachycardias: A systematic review and meta-analysis	29
Evaluating the efficacy of pre-ablation algorithms in WPW syndrome localization: a retrospective study	29
Predicting dementia in patients with atrial fibrillation using machine learning of a large multimodal registry	29
Determinants of mortality after stereotactic radio-ablation for ventricular tachycardia. Results from the international MUSIC consortium	29
Electroanatomic mapping system guided His bundle pacemaker implantation: experience of the His bundle registry graz	29
Comparison of quality-of-life following cryoballoon versus radiofrequency catheter ablation of symptomatic atrial fibrillation - a subanalysis of the FREEZE cohort study	29
Left-bundle branch block, an alert for cardiac resynchronization therapy	29
In memoriam: Stuart J. Connolly, MD, 9 April 1949–2 June 2024	28
Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation	28
Biatrial ablation versus left atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease undergoing valve surgery: a systematic review and meta-analysis	28
Long-term outcome after catheter ablation for fascicular ventricular tachycardia in a single high-volume center in Germany	28
Impact of pulmonary vein anatomy and ostial dimensions on long term outcome after single-shot device guided cryoablation for paroxysmal atrial fibrillation	28
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?	28
Exploring the effects of glucagon-like peptide-1 receptor agonists on ventricular arrhythmias: a propensity score-matched analysis	28
Non-standard approach for device selection. Left bundle branch optimized ICD for patients with heart failure and LBBB	27
Usefulness of simultaneous isolation of the coronary sinus and the left atrial inferior wall for persistent atrial fibrillation refractory to box isolation	27
The impact of the catheter ablation on long-term prognosis in patients with hypertrophic cardiomyopathy and atrial fibrillation	27
Rigorous and long-term cardiac monitoring strategy in cryptogenic stroke or TIA patients in a tertiary care centre results in a two-fold increase in AF detection	27
Volume-weighted unipolar voltage identifies diffuse fibrosis in patients with non-ischemic cardiomyopathy	27
Pulmonary vein isolation with additional substrate ablation for atrial fibrillation results in an increased risk for the development of atypical atrial flutter	27
Evidence for a shift from right ventricular to left ventricular outflow tract origin of idiopathic premature ventricular contractions with advancing age	26
What determines who gets cardiac resynchronization therapy in europe?	26
Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation	26
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation	26
Characterization and clinical significance of hemolysis after pulsed-field ablation for atrial fibrillation: insights from a multicentric analysis	26
Electrophysiologic effects of left bundle branch area pacing: comparing left ventricular septal pacing and left bundle branch pacing	26

Optimized workflow with hybrid (very) high-power short-duration radiofrequency ablation renders point-by-point pulmonary vein isolation as fast and effective as cryoballoon ablation	26
In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project	26
Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator	26
Renal denervation for the management of refractory ventricular arrhythmias	25
Prognostic significance of beat-to-beat variability of spatial heterogeneity of repolarisation analysed from 5-minute resting electrocardiogram in coronary artery disease	25
The impact of atrial fibrillation and atrial tachycardias on the hemodynamic status of patients with pulmonary hypertension	25
Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease	25
Weight-loss management after catheter ablation of atrial fibrillation	25
An automatic single beat algorithm to discriminate farfield from nearfield bipolar voltage electrograms from the pulmonary veins	25
Non-invasive identification of deceleration zones in the atria using imageless ECGI: correlation with contact-mapping	25
Association between amount of biventricular pacing and heart failure status measured by a multisensor implantable defibrillator algorithm	25
Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study	25
Very-early detection of atrial fibrillation in patients after ablation evaluated by a home-based wearable ECG-patch	25
Impact on ganglionated plexi and arrhythmia recurrence of pulmonary vein isolation with pulsed field ablation compared to thermal energy	25
Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016–2019 national readmission database	24
First-line Marshall plan approach in persistent atrial fibrillation: a prospective single-center cohort study	24
A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study)	24
Genotype-phenotype correlation in hypertrophic cardiomyopathy: moving towards precision medicine?	24
Impact of contact force on local impedance measurements in different atrial locations	24
Shift work and incident atrial fibrillation in younger and older individuals	24
Impact of maintenance anaesthetics on total emissions of an atrial fibrillation catheter ablation procedure	24
Catheter ablation for the treatment of ventricular arrhythmias in the early phase following acute coronary syndrome	24
Use of three-dimensional electroanatomic mapping for epicardial access: needle tracking, electrographic characteristics, and clinical application	24
Increased pacemaker implantation and mortality rates in relatives of patients with early-onset sinus node dysfunction: can genetics explain all?	24
Diagnostic accuracy of smartwatches for automated atrial fibrillation detection over time: insights from the basel wearable study	24
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type	24
AV synchrony maintained by a dual-chamber leadless pacemaker in real-world conditions	24
Additional features in Brugada Syndrome stratification: frequent PVC and QRS duration	24
Optimal timing of of cardiac implantable electronic device reoperation	24
Apical versus septal pacing - can we chose the localization of ventricular lead in order to prevent upgrade to cardiac resynchronization therapy?	24
Anatomical and electrophysiological factors involved in atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation	24
Identifying (electrophysiological) predictors of atrial fibrillation recurrences after catheter ablation: first results from the ISOLATION registry	24
Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trial	23
Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison	23
First clinical experience with cardiac magnetic resonance guided typical atrial flutter ablation with the integration of active catheter tracking and electro-anatomical mapping	23
Ventricular septal defect characteristics influence presence and properties of septal anatomical isthmuses in patients with repaired tetralogy of Fallot	23
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates	23
Electroanatomic visualization of coronary arteries: a case series to elicit safety, feasibility, and diagnostic value in complex ablation procedures	23
Recurrent variant of unknown significance in KCNH2 classified through functional characterisation	23
Genetic testing in children with Brugada syndrome: results from a large prospective registry	23
Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker	23
Heterogenous atrial conduction in patients with hypertrophic cardiomyopathy and atrial fibrillation	23
Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family	23
Non-invasive delineation of ventricular tachycardia substrates for cardiac stereotactic body radiotherapy: utility of in-silico pace-mapping	23
Ganglionated plexi ablation impact on AF mechanisms and outcomes in patients with low scar burden	23
Septal flash correction with His-Purkinje pacing predicts echocardiographic response in resynchronization therapy	22
P-wave duration and atrial fibrillation recurrence after catheter ablation, a systematic review and meta-analysis	22
Acute procedural outcomes of left bundle branch area pacing compared to His-bundle pacing	22
Single-center outcome after ablation of atrial fibrillation using very high-power short duration pulmonary vein isolation	22
The effect of thresholding techniques on 3D quantitative scar metrics in patients with implantable cardioverter defibrillator	22
Validation of a machine learning algorithm to identify pulmonary vein isolation during ablation procedures for the treatment of atrial fibrillation: results of the PVISION study	22
Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study	22
Markers of atrial myopathy in the UK Biobank: prevalence, consequences, and risk stratification	22
Pinpointing atrial fibrillation drivers by informed sequential endocardial mapping in the presence and absence of fibrosis: an in-silico study	22
Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project	22
High comorbidity burden is not associated with increased risk of periprocedural pericardial effusionduring left atrial ablation procedures: data from a large tertiary-care ablation center	21
Left bundle branch pacing with normal paced QRS axis produce more physiological left ventricular lateral wall depolarization than its pacing resulting in heart axis deviation	21
Tackling of challenging accessory pathways utilizing open window mapping, does it add benefit?	21
Epicardial mapping as first intention approach for structural ventricular tachycardia ablation	21
Relationship between electrical activity and left atrial volume during atrial fibrillation	21
Endocardial pacing results in better electrical resynchronization and hemodynamic improvement than epicardial pacing in CRT	21
Fluoroless cavotricuspid isthmus radiofrequency ablation of typical atrial flutter achieves success with zero radiation and shorter procedural duration	21
AV block occurrence in normal AV conduction CRT fusion pacing: single center experience	21
Ablation of anomalous mitral annular pathways via transradial access: early hospital discharge due to the covid-19 pandemic	21
Novelty about pocket histology at cardiac implantable electronic device reopening procedures	21
Vascular complications of pulsed-field ablation of atrial fibrillation using a streamlined procedural workflow - when less is not more	20
Procedural safety, short and long-term follow up after pacemaker implantation in nonagenarians	20
Leap or lag: left atrial appendage closure and guidelines	20
In silico biatrial fibrosis ablation improves atrial fibrillation outcome	20
A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis	20
Wearable Smartwatches for Atrial Fibrillation Detection and Burden Estimation After Ablation: Comparison With Continuous Monitoring	20
Risk factors of mortality after secondary procedures during the world-wide randomized antibiotic envelope infection prevention trial (WRAP-IT)	20
Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience	20
Re-recognized the maintenance mechanism of persistent atrial fibrillation via electrogram analysis in termination regions	20
Outcomes of pulmonary vein isolation with radiofrequency balloon vs. cryoballoon ablation: a multi-centric study	20
Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome	20
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement	20
A novel score to predict left atrial appendage thrombus and sludge in patients with persistent atrial fibrillation on chronic anticoagulants	20
Myeloperoxidase as prognostic factor for atrial fibrillation development in patients with ST-segment elevation myocardial infarction	20
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study	20
Deep septal pacing for pacemaker-induced cardiomyopathy	20
Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper	20
Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality	19
Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a ‘heart team’ approach	19
Software-based analysis of T-wave morphology: identifying the electrocardiogram signature of high-risk long QT syndrome	19
Septal venous channel perforation during left bundle branch area pacing: a prospective study	19
Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source	19
Detailed analysis of PAC characteristics in ambulatory ECG data can improve atrial fibrillation risk prediction	19
Zero fluro compared to fluoroscopy guided radiofrequency ablation of typical atrial flutter	19
State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective	19
Progress in atrial fibrillation ablation during 25 years of Europace journal	19
Clinical impact of right ventricular pacing burden in patients with post-transcatheter aortic valve replacement permanent pacemaker implantation	19
Phosphoproteomics of phospholamban R14del heart tissue reveals aberrant regulation of calcium handling and contractility	19
Does radiotherapy effect the voltage output of cardiac implantable electronic devices (CIEDs)?	19
EHRA perspective on the digital data revolution in arrhythmia management: insights from the association’s annual summit	19